Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain

NCT00634010 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT00634010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00634010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 3
Overall status
Terminated
Start date
February 29, 2008
Completion date
January 31, 2015
Enrollment
36 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, solid tumors